Impact of Race on Outcome of Patients Undergoing Rhythm Control of Atrial Fibrillation

  title={Impact of Race on Outcome of Patients Undergoing Rhythm Control of Atrial Fibrillation},
  author={Asad F Durrani and Siva Soma and Andrew D. Althouse and George Leef and Dingxin Qin and Samir F. Saba},
  journal={Journal of Immigrant and Minority Health},
Racial disparities between African American (AA) and White patients have been documented in cardiovascular disease. We investigated whether these disparities exist in patients undergoing rhythm control for atrial fibrillation (AF). 5873 AF patients (241 AA) were followed to the endpoint of death, stroke, or AF recurrence. Invasive procedures for AF rhythm control were examined in both racial groups. Over a mean follow-up time of 40 months, AA patients had a higher adjusted risk of death [HR 1… 
2 Citations


Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
There was a significant AF-sex interaction: AF diminished the female advantage in survival and AF remained significantly associated with excess mortality, with about a doubling of mortality in both sexes in subjects free of valvular heart disease and preexisting cardiovascular disease.
Racial disparities in hospitalizations, procedural treatments and mortality of patients hospitalized with atrial fibrillation.
Using a large, contemporary sample of inpatients, significant racial differences in baseline characteristics, treatments, and outcomes of patients hospitalized with atrial fibrillation are found.
Atrial Fibrillation and Race – A Contemporary Review
It is concluded that addressing disparities in prevention and healthcare resource allocation will likely improve AF-related outcomes in minorities and to meet identified racial disparities.
Use of oral anticoagulants in African-American and Caucasian patients with atrial fibrillation: is there a treatment disparity?
This review discusses racial differences in the epidemiology and treatment of AF between African-American and Caucasian patients, and the effect of race on warfarin and novel oral anticoagulant use is discussed.
Racial Disparities in Awareness and Treatment of Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Black patients with atrial fibrillation were less likely than whites to be aware of having AF or to be treated with warfarin, and potential reasons for the racial disparity inwarfarin treatment warrant further investigation.
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
The data suggest that the elderly are particularly vulnerable to stroke when atrial fibrillation is present, and the effects of hypertension, coronary heart disease, and cardiac failure on the risk of stroke became progressively weaker with increasing age.
Racial differences in the use of cardiac catheterization after acute myocardial infarction.
Racial differences in the use of cardiac catheterization are similar among patients treated by white physicians and those treated by black physicians, suggesting that this pattern of care is independent of the race of the physician.